Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5% minoxidil foam for male androgenic alopecia (real-world, single-arm)
ChiCTR2500113329Phase 4Not yet recruiting
- Sponsor
- China-Japan Friendship Hospital
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of minoxidil in androgenetic alopecia (AGA), sponsored by China-Japan Friendship Hospital. Primary endpoint: Target Area Hair Count (TAHC) at week 24. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
minoxidil
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on ChiCTR2500113329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500113329.